Use of β-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC β-lactamases

被引:22
作者
Black, JA
Thomson, KS
Pitout, JDD [1 ]
机构
[1] Univ Calgary, Calgary Lab Serv, Div Microbiol, Calgary, AB T3C 0J9, Canada
[2] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T3C 0J9, Canada
[3] Creighton Univ, Sch Med, Ctr Res Anti Infect & Biotechnol, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA
关键词
D O I
10.1128/JCM.42.5.2203-2206.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Seeking a simple disk test for detection of organisms producing plasmid-mediated AmpC beta-lactamases, we evaluated the diagnostic utility of the beta-lactamase inhibitors 48-1220 (Ro 48-1220) and LN-2-128. Using NCCLS disk methodology, inhibition zone diameters were determined for five beta-lactam antibiotics tested alone and in combination with 20 mug of either 48-1220 or LN-2-128. Using an increase of 2:4 mm in zone diameter in the presence of an inhibitor as a positive test, cefotetan with LN-2-128 and 48-1220 was adequate for the detection of organisms producing plasmid-mediated AmpCs (specificity of 90% and sensitivity of 100%).
引用
收藏
页码:2203 / 2206
页数:4
相关论文
共 21 条
  • [1] [Anonymous], M100S12 NAT COMM CLI
  • [2] Salmonella enteritidis:: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii
    Barnaud, G
    Arlet, G
    Verdet, C
    Gaillot, O
    Lagrange, PH
    Philippon, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2352 - 2358
  • [3] EXTENDED BROAD-SPECTRUM BETA-LACTAMASE IN KLEBSIELLA PNEUMONIAE INCLUDING RESISTANCE TO CEPHAMYCINS
    BAUERNFEIND, A
    CHONG, Y
    SCHWEIGHART, S
    [J]. INFECTION, 1989, 17 (05) : 316 - 321
  • [4] Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein
    Bradford, PA
    Urban, C
    Mariano, N
    Projan, SJ
    Rahal, JJ
    Bush, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) : 563 - 569
  • [5] Cephalosporin-derived inhibitors of β-lactamase.: Part 4:: The C3 substituent
    Buynak, JD
    Vogeti, L
    Doppalapudi, VR
    Solomon, GM
    Chen, HS
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (12) : 1663 - 1666
  • [6] Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a Veterans Medical Center
    Coudron, PE
    Moland, ES
    Thomson, KS
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (05) : 1791 - 1796
  • [7] Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae:: Isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases
    Coudron, PE
    Hanson, ND
    Climo, MW
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (02) : 772 - 777
  • [8] Ceftriaxone-resistant salmonella infection acquired by a child from cattle.
    Fey, PD
    Safranek, TJ
    Rupp, ME
    Dunne, EF
    Ribot, E
    Iwen, PC
    Bradford, PA
    Angulo, FJ
    Hinrichs, SH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (17) : 1242 - 1249
  • [9] AmpC β-lactamases:: what do we need to know for the future?
    Hanson, ND
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) : 2 - 4
  • [10] Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type β-lactamase exposed during an outbreak of SHV-5 extended-spectrum β-lactamase in a Leeds hospital
    M'Zali, FH
    Heritage, J
    Gascoyne-Binzi, DM
    Denton, M
    Todd, NJ
    Hawkey, PM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (06) : 823 - 831